Welcome to MagneFeCent
Drug delivery solutions

We are developing the next generation 
of drug delivery solutions for glioblastoma
    

 

 

 



 Glioblastoma is the most common type of brain cancer                                                       with glioblastoma survive up to 5 years after the diagnosis

 
 
 
Mail
About